NCT07516925

A Study of Ivonescimab in People With Leiomyosarcoma

RecruitingPHASE2INTERVENTIONAL

Trial Details

Start: 2026-04-01Est. Completion: 2029-04

Enrollment target: 20 participants

Locations

Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States
Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack, New York, United States
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Memorial Sloan Kettering Nassau (Limited Protocol Activities), Rockville Centre, New York, United States

Contact

Sandra D'Angelo, MDzzPDL_MED_Sarcoma_Clinical_Trials <zzPDL_MED_Sarcoma_Clinical_Trials@mskcc.org>

Other microbiome trials you might be interested in

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)Phase 1Recruiting

Adipocytic NeoplasmLiposarcomaAtypical FibroxanthomaAngiomatoid Fibrous HistiocytomaMyoepitheliomaFibrosarcoma NOSMyxofibrosarcomaAngiosarcomaOsteosarcoma, Extraskeletal

The study participant has been diagnosed with non-rhabdomyosarcoma (NRSTS). Primary Objectives Intermediate-Risk * To…

Atlanta, United StatesEst. completion Jun 2034

View Trial →

APX005M and Doxorubicin in Advanced SarcomaPhase 2Completed

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.